Stuart Duty

Insider Reports History

Entity
Individual
Location
22722 29 Th Dr Se, Suite 100, Bothell, WA
Signature
/s/ Michael LaCascia, Attorney-in-Fact for Stuart Duty
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stuart Duty:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Foghorn Therapeutics Inc. Director Stock Options (Right to buy) 50K $208K $4.16 May 1, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K Jan 3, 2025 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40K Aug 28, 2024 Direct
ACHIEVE LIFE SCIENCES, INC. Director Stock Option (right to buy) 31.5K Jan 22, 2024 Direct
ACHIEVE LIFE SCIENCES, INC. Director No securities are beneficially owned 0 Mar 29, 2023 Direct

Insider Reports Filed by Stuart Duty

Symbol Company Period Transactions Value $ Form Type Date Filed Role
FHTX Foghorn Therapeutics Inc. May 1, 2025 1 $208K 4 May 2, 2025 Director
FHTX Foghorn Therapeutics Inc. May 1, 2025 0 $0 3 May 2, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 3, 2025 1 $0 4 Jan 7, 2025 Director
MIST Milestone Pharmaceuticals Inc. Aug 28, 2024 1 $0 4 Aug 29, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 0 $0 3 Jul 17, 2024 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Jan 22, 2024 1 $0 4 Jan 24, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 5, 2024 1 $0 4 Jan 9, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Oct 16, 2023 1 $0 4 Oct 17, 2023 Director
EYPT EyePoint Pharmaceuticals, Inc. Oct 16, 2023 0 $0 3 Oct 17, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 1 $0 4 Jun 9, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 1 $0 4 Mar 30, 2023 Director
ACHV ACHIEVE LIFE SCIENCES, INC. Mar 29, 2023 0 $0 3 Mar 30, 2023 Director